Caption: Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapies, announced today that the Israeli Ministry of Health has approved the company’s request to initiate a Phase II study using its PLacental eXpanded (PLX) cells in th
Credit: Pluristem Therapeutics